Study Comparing A New Drug Containing The Combination Meloxicam And Cyclobenzaprine In The Treatment Of Acute Lumbago
Status:
Withdrawn
Trial end date:
2013-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy end tolerability of a new drug containing
the combination meloxicam and cyclobenzaprine (7,5/10mg) and the same components alone in the
treatment of acute lumbago.